HCA Healthcare (NYSE:HCA) Given New $260.00 Price Target at Mizuho

HCA Healthcare (NYSE:HCAGet Rating) had its target price reduced by equities researchers at Mizuho from $290.00 to $260.00 in a report released on Tuesday, The Fly reports. Mizuho’s price target would suggest a potential upside of 23.33% from the stock’s current price.

A number of other equities analysts have also commented on HCA. Truist Financial lowered their price objective on HCA Healthcare from $310.00 to $250.00 and set a “buy” rating on the stock in a research note on Monday, April 25th. BMO Capital Markets decreased their price target on HCA Healthcare from $275.00 to $240.00 in a research note on Tuesday, April 26th. TheStreet upgraded HCA Healthcare from a “c+” rating to a “b-” rating in a research note on Monday, March 21st. StockNews.com downgraded HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, April 25th. Finally, Wells Fargo & Company lowered their price objective on HCA Healthcare from $267.00 to $227.00 and set an “equal weight” rating for the company in a research report on Monday, April 25th. Seven investment analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average target price of $259.27.

Shares of NYSE HCA opened at $210.82 on Tuesday. The firm has a market cap of $63.67 billion, a P/E ratio of 9.92, a price-to-earnings-growth ratio of 1.29 and a beta of 1.60. The company has a current ratio of 1.43, a quick ratio of 1.24 and a debt-to-equity ratio of 87.46. HCA Healthcare has a 1-year low of $199.76 and a 1-year high of $279.02. The business’s 50 day moving average is $252.62 and its 200-day moving average is $247.77.

HCA Healthcare (NYSE:HCAGet Rating) last posted its quarterly earnings data on Friday, April 22nd. The company reported $4.12 EPS for the quarter, missing the Zacks’ consensus estimate of $4.25 by ($0.13). HCA Healthcare had a return on equity of 405.72% and a net margin of 11.40%. The company had revenue of $14.95 billion for the quarter, compared to the consensus estimate of $14.72 billion. During the same quarter last year, the business earned $4.14 EPS. HCA Healthcare’s revenue was up 6.9% on a year-over-year basis. Analysts forecast that HCA Healthcare will post 17.15 EPS for the current year.

HCA Healthcare announced that its Board of Directors has approved a share repurchase plan on Thursday, January 27th that permits the company to repurchase $8.00 billion in shares. This repurchase authorization permits the company to repurchase up to 10.9% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s board of directors believes its stock is undervalued.

In related news, SVP Joseph A. Sowell III sold 11,522 shares of the company’s stock in a transaction that occurred on Friday, March 11th. The stock was sold at an average price of $269.00, for a total value of $3,099,418.00. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Andrea B. Smith acquired 1,160 shares of the company’s stock in a transaction that occurred on Thursday, April 28th. The stock was purchased at an average price of $213.63 per share, for a total transaction of $247,810.80. Following the purchase, the director now owns 2,239 shares of the company’s stock, valued at approximately $478,317.57. The disclosure for this purchase can be found here. Insiders own 1.50% of the company’s stock.

Several large investors have recently bought and sold shares of HCA. Equitec Proprietary Markets LLC purchased a new stake in shares of HCA Healthcare during the fourth quarter worth $26,000. Baltimore Washington Financial Advisors Inc. purchased a new stake in shares of HCA Healthcare during the fourth quarter worth $26,000. Amplius Wealth Advisors LLC purchased a new stake in HCA Healthcare during the fourth quarter valued at about $27,000. PYA Waltman Capital LLC purchased a new stake in HCA Healthcare during the fourth quarter valued at about $31,000. Finally, Ellevest Inc. boosted its position in HCA Healthcare by 1,172.7% during the fourth quarter. Ellevest Inc. now owns 140 shares of the company’s stock valued at $36,000 after buying an additional 129 shares during the period. Hedge funds and other institutional investors own 67.87% of the company’s stock.

About HCA Healthcare (Get Rating)

HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Stories

The Fly logo

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.